期刊文献+

遗传性凝血因子Ⅶ缺乏症研究进展 被引量:3

Research Progress in Inherited Coagulation Factor Ⅶ Deficiency
下载PDF
导出
摘要 遗传性凝血因子Ⅶ(FⅦ)缺乏症是一种在临床上非常少见的出血性疾病,常与FⅦ基因缺陷有关,其临床表型往往与FⅦ基因的突变类型及突变区域密切相关。近年来国际上相继进行了几个较大的遗传性FⅦ缺乏症相关研究的合作项目,发现了新的基因突变,丰富了疾病相关基因突变数据库,而且在疾病基因治疗方面也取得了可喜的进展。 Inherited coagulation factor Ⅶ deficiency is a rare hemorrhagic disease,frequently associated with FⅦ gene deficiency.The clinical phenotype is closely related to factor Ⅶ gene mutation type and region.In recent years,several international collaborative projects on such disease have been carried out,identifying some new factor Ⅶ gene mutations and enriching the disease associated gene mutation database.Additionally,gene therapy has also made encouraging progress.This paper mainly reviews the above issues.
出处 《医学综述》 2010年第22期3372-3375,共4页 Medical Recapitulate
关键词 凝血因子Ⅶ 缺乏症 研究进展 Coagulation factor Ⅶ Deficiency Research progress
  • 相关文献

参考文献21

  • 1Alexander B,Goldstein R,Landwehr G,et al.Congenital SPCA deficiency:a hitherto unrecognized coagulation defect with hemorrhage rectified by serum and serum fractions[J].J Clin Invest,1951,30(6):596-608.
  • 2O'Hara PJ,Grant FJ,Haldeman BA,et al.Nucleotide sequence of the gene ceding for human factor Ⅶ,a vitamin K-dependent protein participating in blood coagulation[J].Proc Natl Acad Sci USA,1987,84(15):5158-5162.
  • 3McVey JH,Boswell E,Mumford AD,et al.Factor Ⅶ deficiency and the FⅦ mutation database[J].Hum Murat,2001,17(1):3-17.
  • 4Mariani G,Herrmann FH,Dolce A,et al.Clinical phenotypes and factor Ⅶ genotype in congenital factor Ⅶ deficiency[J].Thromb Haemost,2005,93(3):481-487.
  • 5Herrmann FH,Wulff K,Auerswald G,et al.Factor Ⅶ deficiency:clineal manifestation of 717 subjects from Europe and Latin America with mutations in the factor 7 gene[J].Haemophilia,2009,15(1):267-280.
  • 6Peyvandi F,Jenkins PV,Marmueci PM,et al.Molecular characterisation and three-dimensional structural analysis of mutations in 21unrealted families with inherited factor Ⅶ deficiency[J].Thromb Haemost,2000,84(2):250-257.
  • 7Takamiya O,Kimura S.Molecular mechanism of dysfunctional factor Ⅶ associated with the homozygous missense mutation 331Gly to Ser[J].Thromb Haemost,2005,93(3):414-419.
  • 8Pruthi RK,Rodriguez V,Allen C,et al.Molecular analysis in a patient with sever factor Ⅶ deficiency and an inhibitor:report of a novel mutation(S103G)[J].Eur J Haematol,2007,79(4):354-359.
  • 9Gomez K,Laffan MA,Kemball-Cook G,et al.Two novel mutations in severe factor Ⅶ deficiency[J].Br J Hanmest,2004,126(1):105-110.
  • 10丁秋兰,王鸿利,王学锋,王明山,傅启华,武文漫,胡翊群,王振义.重型遗传性凝血因子Ⅶ缺陷症家系分子遗传学分析[J].中华内科杂志,2003,42(10):692-696. 被引量:3

共引文献2

同被引文献48

  • 1邓家栋 杨崇礼 杨天楹 等.临床血液学[M].上海:上海科学技术出版社,2001.1085-1090.
  • 2Mayer SA, Brun NC, Begtrop K, et al. Recombinant activated factor Vli for acute intracerebral hemorrhage. N Engl J Med, 2005,352:777-785.
  • 3Mayer SA, Brun NC, Begtrop K, et al. Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med,2008, 358:2127-2137.
  • 4Bartal C, Freedman J, Bowman K, et al. Coagulopathic patients with traumatic intracranial bleeding: defining the role of recombinant factor VIIa. J Tranma,2007, 63:725-732.
  • 5White CE, Schrank AE, Baskin TW, et al. Effects of recom- binant activated factor VII in traumatic nonsurgical intracranial hemorrhage. J Curr Surg,2006,63:310-317.
  • 6Stein DM, Dutton RP, Kramer ME, et al. Recombinant factor VIIa: decreasing time to intervention in coagulopathic patients with severe traumatic brain injury. J Trauma,2008,64:620-627.
  • 7Stein Dbi, Dutton RP, Kramer ME, et al. Reversal of coag- ulopathy in critically ill patients with traumatic brain injury: recombinant factor VIIa is more cost-effective than plasma. J Trauma, 2009, 66:63-72.
  • 8Brown CV, Foulkrod KH, Lopez D. Recombinant Factor VIIa for the correction of coagulopathy before emergent craniotomy in blunt trauma Patients. J Tranma,2010, 68:348 - 352.
  • 9Zaaroor M, Soustiel JF, Brenner B, et al. Administration off label of recombinant factor-VIIa (rFVIIa) to patients with blunt or penetrating brain injury without coagulopathy. Acta Neurochir, 2008,150:663-668.
  • 10Martinowitz U, Miehaelson M. The Israeli Muhidiseiplinary rFVIIa Task Force. Guidelines for the use of recombinant activated factor VII (rFVlla) in uncontrolled bleeding: a report by the israeli Multidiseiplinary rFVIIa Task Force. J Thremb Haemost,2005, 640-648.

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部